UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6823) 6823
Book Chapter (13) 13
Conference Proceeding (10) 10
Book / eBook (4) 4
Dissertation (3) 3
Magazine Article (3) 3
Publication (3) 3
Web Resource (2) 2
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6200) 6200
camptothecin - analogs & derivatives (5912) 5912
science & technology (4881) 4881
life sciences & biomedicine (4620) 4620
camptothecin - administration & dosage (3807) 3807
antineoplastic combined chemotherapy protocols - therapeutic use (3633) 3633
female (3593) 3593
male (3367) 3367
oncology (3284) 3284
middle aged (2914) 2914
aged (2735) 2735
camptothecin - therapeutic use (2410) 2410
adult (2220) 2220
irinotecan (1911) 1911
colorectal neoplasms - drug therapy (1841) 1841
treatment outcome (1619) 1619
fluorouracil - administration & dosage (1516) 1516
chemotherapy (1487) 1487
cancer (1360) 1360
camptothecin - adverse effects (1336) 1336
animals (1266) 1266
colorectal neoplasms - pathology (1175) 1175
antineoplastic combined chemotherapy protocols - adverse effects (1160) 1160
colorectal cancer (1131) 1131
pharmacology & pharmacy (1129) 1129
leucovorin - administration & dosage (1048) 1048
organoplatinum compounds - administration & dosage (995) 995
antineoplastic agents - therapeutic use (932) 932
antineoplastic agents, phytogenic - therapeutic use (927) 927
camptothecin - pharmacology (888) 888
drug administration schedule (829) 829
mice (794) 794
fluorouracil - therapeutic use (757) 757
aged, 80 and over (717) 717
antineoplastic combined chemotherapy protocols - administration & dosage (717) 717
disease-free survival (710) 710
lung neoplasms - drug therapy (704) 704
cisplatin - administration & dosage (701) 701
camptothecin (695) 695
survival rate (680) 680
antineoplastic agents, phytogenic - administration & dosage (668) 668
deoxycytidine - analogs & derivatives (649) 649
adenocarcinoma - drug therapy (645) 645
neoplasm staging (644) 644
care and treatment (625) 625
cell line, tumor (622) 622
liver neoplasms - secondary (612) 612
bevacizumab (607) 607
camptothecin - pharmacokinetics (600) 600
neoplasm metastasis (594) 594
metastasis (592) 592
medicine & public health (574) 574
neoplasms - drug therapy (557) 557
retrospective studies (543) 543
research (539) 539
survival analysis (529) 529
dose-response relationship, drug (511) 511
leucovorin - therapeutic use (496) 496
liver neoplasms - drug therapy (495) 495
prognosis (493) 493
antibodies, monoclonal, humanized (486) 486
organoplatinum compounds - therapeutic use (485) 485
antineoplastic agents (476) 476
deoxycytidine - administration & dosage (475) 475
antineoplastic agents - administration & dosage (451) 451
drug therapy (449) 449
combined modality therapy (447) 447
cetuximab (443) 443
analysis (439) 439
colorectal neoplasms - mortality (439) 439
stomach neoplasms - drug therapy (432) 432
antimitotic agents (431) 431
antibodies, monoclonal - administration & dosage (420) 420
fluorouracil - adverse effects (412) 412
topoisomerase i inhibitors (392) 392
colorectal neoplasms - genetics (383) 383
tumors (378) 378
antineoplastic agents, phytogenic - adverse effects (372) 372
camptothecin - chemistry (366) 366
infusions, intravenous (363) 363
antineoplastic agents - pharmacology (362) 362
disease progression (362) 362
mice, nude (361) 361
colonic neoplasms - drug therapy (360) 360
oxaliplatin (356) 356
cancer research (353) 353
pharmacology/toxicology (350) 350
surgery (341) 341
capecitabine (340) 340
chemotherapy, adjuvant (334) 334
drug resistance, neoplasm (330) 330
drug combinations (328) 328
clinical trials (321) 321
follow-up studies (314) 314
time factors (313) 313
carcinoma, non-small-cell lung - drug therapy (310) 310
clinical trials as topic (310) 310
cancer therapies (302) 302
antineoplastic agents, phytogenic - pharmacology (297) 297
diarrhea - chemically induced (295) 295
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6249) 6249
Japanese (632) 632
Chinese (83) 83
French (74) 74
German (43) 43
Italian (27) 27
Hungarian (14) 14
Russian (10) 10
Korean (7) 7
Spanish (6) 6
Czech (3) 3
Dutch (3) 3
Lithuanian (3) 3
Portuguese (3) 3
Croatian (1) 1
Danish (1) 1
Norwegian (1) 1
Polish (1) 1
Romanian (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Supportive care in cancer, ISSN 0941-4355, 6/2015, Volume 23, Issue 6, pp. 1769 - 1777
The granisetron transdermal system (GTS) showed non-inferior efficacy to oral granisetron to control chemotherapy-induced nausea and vomiting (CINV) during... 
CINV | Pain Medicine | Granisetron | Nursing | Rehabilitation Medicine | Transdermal granisetron | Medicine & Public Health | Moderately emetogenic chemotherapy | Oncology | Nursing Management/Nursing Research | Health Care Sciences & Services | Rehabilitation | Life Sciences & Biomedicine | Science & Technology | Prospective Studies | Nausea - chemically induced | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents - therapeutic use | Administration, Cutaneous | Fluorouracil - therapeutic use | Leucovorin - adverse effects | Fluorouracil - adverse effects | Antineoplastic Agents - adverse effects | Antiemetics - therapeutic use | Adult | Antiemetics - adverse effects | Female | Leucovorin - therapeutic use | Safety | Nausea - drug therapy | Granisetron - therapeutic use | Republic of Korea | Camptothecin - analogs & derivatives | Camptothecin - adverse effects | Granisetron - adverse effects | Camptothecin - therapeutic use | Vomiting - drug therapy | Remission Induction | Neoplasms - drug therapy | Vomiting - chemically induced | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cisplatin - adverse effects | Aged | Organoplatinum Compounds - therapeutic use | Organoplatinum Compounds - adverse effects | Chemotherapy | Nausea | Comparative analysis | Transdermal medication | Cancer | Drug therapy | Vomiting | Index Medicus
Journal Article
Cochrane library, ISSN 1465-1858, 11/2018, Volume 2018, Issue 11, pp. CD008218 - CD008218
Background This is an updated version of the original Cochrane Review published in September 2014. The most common primary brain tumours in adults are gliomas.... 
Hypertension | Camptothecin | Neurological | Glioblastoma | Neoplasm Recurrence, Local | Neovascularization, Pathologic | Antineoplastic Agents | Angiogenesis Inhibitors | Bevacizumab | Brain Neoplasms | Randomized Controlled Trials as Topic | Primary brain tumours | Neuro‐oncology | Antibodies, Monoclonal, Humanized | Dacarbazine | Irinotecan | Neurology | Progression‐Free Survival | Lomustine | Snake Venoms | Temozolomide | Medicine General & Introductory Medical Sciences | Proteinuria | Cancer | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Neovascularization, Pathologic - mortality | Bevacizumab - therapeutic use | Snake Venoms - therapeutic use | Dacarbazine - therapeutic use | Humans | Neoplasm Recurrence, Local - drug therapy | Antineoplastic Agents - therapeutic use | Brain Neoplasms - blood supply | Irinotecan - therapeutic use | Temozolomide - therapeutic use | Proteinuria - chemically induced | Hypertension - chemically induced | Dacarbazine - analogs & derivatives | Angiogenesis Inhibitors - therapeutic use | Lomustine - therapeutic use | Brain Neoplasms - mortality | Angiogenesis Inhibitors - adverse effects | Camptothecin - analogs & derivatives | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Camptothecin - therapeutic use | Brain Neoplasms - drug therapy | Neovascularization, Pathologic - drug therapy | Progression-Free Survival | Glioblastoma - drug therapy | Glioblastoma - blood supply | Glioblastoma - mortality | Index Medicus
Journal Article